148763-61-5

Basic information

• Product Name: (2S)-2-({[(5S,6S)-1,6,9,14-tetrahydroxy-5-{[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-{[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]oxy}-11-methoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetracen
• CAS NO: 148763-61-5
• Molecular Formula: C₄₁H₄₄N₂O₂₀
• Molecular Weight: 884.7895
• Mol File: 148763-61-5.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 1145.4°C at 760 mmHg
• Flash Point: 646.5°C
• Density: 1.74g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.746
• CAS DataBase Reference: (2S)-2-({[(5S,6S)-1,6,9,14-tetrahydroxy-5-{[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-{[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]oxy}-11-methoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetracen(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-2-({[(5S,6S)-1,6,9,14-tetrahydroxy-5-{[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-{[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]oxy}-11-methoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetracen(148763-61-5)
• EPA Substance Registry System: (2S)-2-({[(5S,6S)-1,6,9,14-tetrahydroxy-5-{[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-{[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]oxy}-11-methoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetracen(148763-61-5)

Safety Data

• Hazardous Substances Data: 148763-61-5(Hazardous Substances Data)

Usage

Description

(2S)-2-([(5S,6S)-1,6,9,14-tetrahydroxy-5-[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxytetrahydro-2H-pyran-2-yl]oxy-11-methoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetracen is a complex organic compound characterized by its multiple hydroxyl groups and a benzo[a]tetracen core. It features a variety of sugars and amino groups, contributing to its intricate molecular structure. (2S)-2-([(5S,6S)-1,6,9,14-tetrahydroxy-5-[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxytetrahydro-2H-pyran-2-yl]oxy-11-methoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetracen's complexity suggests it may possess a broad spectrum of biological activities, making it a candidate for various applications in medicinal chemistry and drug development.

Uses

Used in Pharmaceutical Industry:
(2S)-2-([(5S,6S)-1,6,9,14-tetrahydroxy-5-[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxytetrahydro-2H-pyran-2-yl]oxy-11-methoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetracen is used as a potential therapeutic agent for various medical conditions due to its complex structure and multiple functional groups that may interact with biological targets.
Used in Drug Development:
In the field of drug development, (2S)-2-([(5S,6S)-1,6,9,14-tetrahydroxy-5-[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxytetrahydro-2H-pyran-2-yl]oxy-11-methoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetracen could be utilized as a lead compound for the design and synthesis of new drugs targeting specific diseases or conditions. Its unique structure may offer novel mechanisms of action or improved pharmacokinetic properties.
Used in Medicinal Chemistry Research:
(2S)-2-([(5S,6S)-1,6,9,14-tetrahydroxy-5-[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxytetrahydro-2H-pyran-2-yl]oxy-11-methoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetracen may serve as a valuable compound in medicinal chemistry research, where it can be studied for its interactions with various biological targets, potentially leading to the discovery of new therapeutic strategies or the optimization of existing drug candidates.